Serum levels of hormones regulating appetite in patients with cystic fibrosis − a single-center, cross-sectional study

Cystic fibrosis (CF), which is the most common inherited genetically determined disease caused by a mutation in the gene for the CF transmembrane conductance regulator protein. Pulmonary failure is the leading cause of death in this population, while the dysregulation of endocrine system creates sig...

Full description

Bibliographic Details
Main Authors: Sabina Galiniak, Rafał Podgórski, Marta Rachel, Artur Mazur
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.992667/full
_version_ 1798019594592452608
author Sabina Galiniak
Rafał Podgórski
Marta Rachel
Artur Mazur
author_facet Sabina Galiniak
Rafał Podgórski
Marta Rachel
Artur Mazur
author_sort Sabina Galiniak
collection DOAJ
description Cystic fibrosis (CF), which is the most common inherited genetically determined disease caused by a mutation in the gene for the CF transmembrane conductance regulator protein. Pulmonary failure is the leading cause of death in this population, while the dysregulation of endocrine system creates significant disorders, including malnutrition, underweight, and CF-related diabetes. Therefore, the objective of our study was to determine the following hormones in the serum of patients with CF: ghrelin, putative peptide YY (PYY), Agouti-signaling protein (ASP), and alpha-melanocyte-stimulating hormone (α-MSH). To our knowledge, serum levels of PYY, ASP, and α-MSH have not yet been assessed in CF. For this purpose, we measured hormone levels using enzyme-linked immunosorbent assays in 38 patients from the local CF care center, as well as 16 sex- and age-matched healthy controls. Moreover, we estimated the correlations between the tested hormones and the parameters of the patients’ clinical status. In this study, we found sinificantly reduced serum levels of ghrelin and ASP in patients with CF (p<0.01). There was no difference in PYY and α-MSH levels between participants with CF and healthy subjects. Furthermore, there was no difference in hormone levels between females and males with CF. The type of gene mutation (homozygous or heterozygous for ΔF508) had no effect on hormone levels. Ghrelin was negatively correlated with age, body mass index, and C-reactive protein. PYY was negatively associated with the age of the patients. Hormone dysregulation in CF may contribute to decreased appetite, as well as many other disturbed processes. Therefore, ghrelin appears to play a key role in the regulation of energy management of CF. Future multicenter and multidisciplinary studies should focus on an unequivocal understanding of the role of these hormones in CF.
first_indexed 2024-04-11T16:43:13Z
format Article
id doaj.art-f4c0f8491cb14aebbefcc3e108b3d501
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-11T16:43:13Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-f4c0f8491cb14aebbefcc3e108b3d5012022-12-22T04:13:38ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-10-011310.3389/fendo.2022.992667992667Serum levels of hormones regulating appetite in patients with cystic fibrosis − a single-center, cross-sectional studySabina GaliniakRafał PodgórskiMarta RachelArtur MazurCystic fibrosis (CF), which is the most common inherited genetically determined disease caused by a mutation in the gene for the CF transmembrane conductance regulator protein. Pulmonary failure is the leading cause of death in this population, while the dysregulation of endocrine system creates significant disorders, including malnutrition, underweight, and CF-related diabetes. Therefore, the objective of our study was to determine the following hormones in the serum of patients with CF: ghrelin, putative peptide YY (PYY), Agouti-signaling protein (ASP), and alpha-melanocyte-stimulating hormone (α-MSH). To our knowledge, serum levels of PYY, ASP, and α-MSH have not yet been assessed in CF. For this purpose, we measured hormone levels using enzyme-linked immunosorbent assays in 38 patients from the local CF care center, as well as 16 sex- and age-matched healthy controls. Moreover, we estimated the correlations between the tested hormones and the parameters of the patients’ clinical status. In this study, we found sinificantly reduced serum levels of ghrelin and ASP in patients with CF (p<0.01). There was no difference in PYY and α-MSH levels between participants with CF and healthy subjects. Furthermore, there was no difference in hormone levels between females and males with CF. The type of gene mutation (homozygous or heterozygous for ΔF508) had no effect on hormone levels. Ghrelin was negatively correlated with age, body mass index, and C-reactive protein. PYY was negatively associated with the age of the patients. Hormone dysregulation in CF may contribute to decreased appetite, as well as many other disturbed processes. Therefore, ghrelin appears to play a key role in the regulation of energy management of CF. Future multicenter and multidisciplinary studies should focus on an unequivocal understanding of the role of these hormones in CF.https://www.frontiersin.org/articles/10.3389/fendo.2022.992667/fullappetitecystic fibrosisendocrine systemhormonesghrelin
spellingShingle Sabina Galiniak
Rafał Podgórski
Marta Rachel
Artur Mazur
Serum levels of hormones regulating appetite in patients with cystic fibrosis − a single-center, cross-sectional study
Frontiers in Endocrinology
appetite
cystic fibrosis
endocrine system
hormones
ghrelin
title Serum levels of hormones regulating appetite in patients with cystic fibrosis − a single-center, cross-sectional study
title_full Serum levels of hormones regulating appetite in patients with cystic fibrosis − a single-center, cross-sectional study
title_fullStr Serum levels of hormones regulating appetite in patients with cystic fibrosis − a single-center, cross-sectional study
title_full_unstemmed Serum levels of hormones regulating appetite in patients with cystic fibrosis − a single-center, cross-sectional study
title_short Serum levels of hormones regulating appetite in patients with cystic fibrosis − a single-center, cross-sectional study
title_sort serum levels of hormones regulating appetite in patients with cystic fibrosis a single center cross sectional study
topic appetite
cystic fibrosis
endocrine system
hormones
ghrelin
url https://www.frontiersin.org/articles/10.3389/fendo.2022.992667/full
work_keys_str_mv AT sabinagaliniak serumlevelsofhormonesregulatingappetiteinpatientswithcysticfibrosisasinglecentercrosssectionalstudy
AT rafałpodgorski serumlevelsofhormonesregulatingappetiteinpatientswithcysticfibrosisasinglecentercrosssectionalstudy
AT martarachel serumlevelsofhormonesregulatingappetiteinpatientswithcysticfibrosisasinglecentercrosssectionalstudy
AT arturmazur serumlevelsofhormonesregulatingappetiteinpatientswithcysticfibrosisasinglecentercrosssectionalstudy